Literature DB >> 16685208

Interleukin 6 is associated with subclinical atherosclerosis: a link with soluble intercellular adhesion molecule 1.

Jacques Amar1, Josette Fauvel, Ludovic Drouet, Jean Bernard Ruidavets, Bertrand Perret, Bernard Chamontin, Henri Boccalon, Jean Ferrieres.   

Abstract

BACKGROUND: Among the markers of inflammation, a cytokine, interleukin (IL)-6, promotes the expression of intercellular adhesion molecule 1 (ICAM-1), C-reactive protein (CRP) synthesis, and leads to a series of procoagulant actions with potential major implications on the progression of atherosclerosis. AIM OF THE STUDY: To analyse in a population-based study, the relationship between IL-6 and atherosclerotic lesions and the role of serum ICAM-1 and CRP on this relationship. POPULATION: Among 1015 individuals randomly recruited between 1995 and 1997 in Haute-Garonne, a French region with a low cardiovascular risk, 953 subjects with complete data for all measurements were analysed. Common carotid intima-media thickness (IMT) and the presence of plaques in the carotid and femoral arteries were assessed by ultrasonography.
RESULTS: Quartiles of IL-6, serum ICAM-1 and CRP were positively associated with plaques and IMT. After adjustment for traditional risk factors, IL-6 (P < 0.001) and serum ICAM-1 (P < 0.002) remained positively associated with plaques but not CRP (P = 0.20). Neither IL-6, nor serum ICAM-1, nor CRP were independently associated with IMT. When serum ICAM-1 was entered into the model in addition to traditional risk factors and IL-6, the percentage of variance in the number of plaques explained by the model did not increase significantly.
CONCLUSION: IL-6 levels are associated with subclinical atherosclerotic lesions independently of traditional risk factors; the influence of IL-6 on ICAM-1 secretion may play a role in this association. These results argue the interest of IL-6 in the stratification of cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16685208     DOI: 10.1097/01.hjh.0000226198.44181.0c

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  26 in total

1.  Vascular hypercontractility and endothelial dysfunction before development of atherosclerosis in moderate dyslipidemia: role for nitric oxide and interleukin-6.

Authors:  Vanessa Cavieres; Karla Valdes; Brayan Moreno; Rodrigo Moore-Carrasco; Daniel R Gonzalez
Journal:  Am J Cardiovasc Dis       Date:  2014-10-11

2.  Negative and competitive social interactions are related to heightened proinflammatory cytokine activity.

Authors:  Jessica J Chiang; Naomi I Eisenberger; Teresa E Seeman; Shelley E Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

3.  Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.

Authors:  A Ross Eckard; C T Longenecker; Y Jiang; S M Debanne; D Labbato; N Storer; G A McComsey
Journal:  HIV Med       Date:  2014-03-20       Impact factor: 3.180

4.  Differential associations between soluble cellular adhesion molecules and atherosclerosis in the Dallas Heart Study: a distinct role for soluble endothelial cell-selective adhesion molecule.

Authors:  Anand Rohatgi; Andrew W Owens; Amit Khera; Colby R Ayers; Kamakki Banks; Sandeep R Das; Jarett D Berry; Darren K McGuire; James A de Lemos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10       Impact factor: 8.311

5.  Correlative association of interleukin-6 with intima media thickness: a meta-analysis.

Authors:  Bo Zhang; Jing Wang; Yong Xu; Xiao Zhou; Junsong Liu; Jing Xu; Bo Li; Guang Zhi
Journal:  Int J Clin Exp Med       Date:  2015-03-15

6.  Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy.

Authors:  Allison Ross Eckard; Ying Jiang; Sara M Debanne; Nicholas T Funderburg; Grace A McComsey
Journal:  J Infect Dis       Date:  2014-01-09       Impact factor: 5.226

Review 7.  Microbial translocation in the pathogenesis of HIV infection and AIDS.

Authors:  Giulia Marchetti; Camilla Tincati; Guido Silvestri
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

8.  Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy.

Authors:  Allison C Ross; Rachel Armentrout; Mary Ann O'Riordan; Norma Storer; Nesrine Rizk; Danielle Harrill; Dalia El Bejjani; Grace A McComsey
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-15       Impact factor: 3.731

9.  Expanded network of inflammatory markers of atherogenesis: where are we now?

Authors:  Seyed Hesameddin Abbasi; Mohammad Ali Boroumand
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

10.  Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.

Authors:  Allison C Ross; Nesrine Rizk; Mary Ann O'Riordan; Vikram Dogra; Dalia El-Bejjani; Norma Storer; Danielle Harrill; Marisa Tungsiripat; Jerome Adell; Grace A McComsey
Journal:  Clin Infect Dis       Date:  2009-10-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.